Back to all studies
🛡️
Phase 3
Vaccine
in-person
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
Sponsored by ModernaTX, Inc.
Compensation
$500–$2,500
Duration
3 months
Location
Nationwide
About this study
The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.
Who can participate
- • Adults aged 18–99
- • All genders welcome
- • Diagnosed with or experiencing influenza
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.